Enrollment Clinical Trial Specified | Premenopausal state | Postmenopausal state
Item
patients must either be concurrently enrolling or previously enrolled to canada (can) national cancer institute of canada (ncic) study ma.32 (can-ncic-ma.32) (ma.32); eligible patients may be either pre- or post-menopausal
boolean
C1516879 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,3])
C0232969 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
Breast Carcinoma Hormone Receptor Negative
Item
patients must have hormone receptor-negative breast cancer
boolean
C0678222 (UMLS CUI [1,1])
C0019929 (UMLS CUI [1,2])
C1513916 (UMLS CUI [1,3])
Breast Density Percentage BI-RADS
Item
patients must have breast density ≥ 25% (correlating with the breast imaging-reporting and data [birad]-2 category of "scattered fibroglandular densities" or greater)
boolean
C1659543 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C1511314 (UMLS CUI [1,3])
Digital mammogram Cranio-caudal projection
Item
baseline digital mammograms taken within 12 months prior to registration to ma.32, with at least a craniocaudal (cc) view used for enrollment to ma.32 must be available for submission; if the patient has previously enrolled to ma.32 and one year has elapsed from baseline mammograms, one-year mammograms must also be available for submission
boolean
C3862913 (UMLS CUI [1,1])
C0442215 (UMLS CUI [1,2])
Breast Contralateral Unaffected | Cancer Previous Absent | Prior radiation therapy Absent | Breast implants Absent | Breast surgery Plan Absent | Biopsy Previous allowed
Item
contralateral unaffected breast in place (with no prior cancer or radiation, no implants, and no plan for breast surgery on contralateral breast over the course of the study); women with a prior biopsy on the unaffected breast are eligible
boolean
C0006141 (UMLS CUI [1,1])
C0441988 (UMLS CUI [1,2])
C2986417 (UMLS CUI [1,3])
C0006826 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0279134 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0179412 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C3714726 (UMLS CUI [5,1])
C1301732 (UMLS CUI [5,2])
C0332197 (UMLS CUI [5,3])
C0005558 (UMLS CUI [6,1])
C0205156 (UMLS CUI [6,2])
C0683607 (UMLS CUI [6,3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
Prior Therapy
Item
prior concurrent therapy:
boolean
C1514463 (UMLS CUI [1])
ID.9
Item
see disease characteristics
boolean
Gender | Hormone Therapy | Tamoxifen | Aromatase Inhibitors
Item
women receiving endocrine therapy (e.g., tamoxifen, aromatase inhibitors) are not eligible
boolean
C0079399 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
C0039286 (UMLS CUI [3])
C0593802 (UMLS CUI [4])